T1	Participants 61 82	breast cancer surgery
T2	Participants 171 187	female patients.
T3	Participants 271 318	adult patients undergoing breast cancer surgery
T4	Participants 328 373	Sixty-eight women premedicated with midazolam
T5	Participants 1579 1600	breast cancer surgery